Polyamine-mediated sensitization of Klebsiella pneumoniae to macrolides through a dual mode of action
Joshua M. E. AdamsiD, Peri B. Moulding, Omar M. El-HalfawyiD
Abstract
Chemicals bacteria encounter at the infection site could shape their stress and antibiotic responses; such effects are typically undetected in standard lab conditions. Polyamines are small molecules typically overproduced by the host during infection and have been shown to alter bacterial stress responses. We sought to determine the effect of polyamines on the antibiotic response of Klebsiella pneumoniae, a Gram-negative priority pathogen. Interestingly, putrescine and other natural polyamines sensitized K. pneumoniae to azithromycin, a macrolide protein translation inhibitor typically used for Gram-positive bacteria. This synergy was further potentiated in the physiological buffer, bicarbonate. Chemical genomic screens suggested a dual mechanism whereby putrescine acts at the membrane and ribosome levels. Putrescine permeabilized the outer membrane of K. pneumoniae (NPN and {beta}-lactamase assays) and the inner membrane (Escherichia coli {beta}-galactosidase assays). Chemically and genetically perturbing membranes led to a loss of putrescine-azithromycin synergy. Putrescine also inhibited protein synthesis in an E. coli-derived cell-free protein expression assay simultaneously monitoring transcription and translation. Profiling the putrescine-azithromycin synergy against a combinatorial array of antibiotics targeting various ribosomal sites suggested that putrescine acts as tetracyclines targeting the 30S ribosomal acceptor site. Next, exploiting the natural polyamine-azithromycin synergy, we screened a polyamine analog library for azithromycin adjuvants, discovering four azithromycin synergists with activity starting from the low micromolar range and mechanisms similar to putrescine. This work sheds light on the bacterial antibiotic responses under conditions more reflective of those at the infection site and provides a new strategy to extend the macrolide spectrum to drug-resistant K. pneumoniae.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 5
- FWCI
- 0.56
- Field percentile
- top 45%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Azithromycin possesses biofilm-inhibitory activity and potentiates non-bactericidal colistin methanesulfonate against Klebsiella pneumonia
O. V. Moshynets, T. P. Baranovskyi, … A. Spiers·bioRxiv·Feb 17, 2022
- Transcriptomics reveals how minocycline-colistin synergy overcomes antibiotic resistance in multidrug-resistant Klebsiella pneumoniae
T. Brennan-Krohn, A. Grote, … A. M. Earl·Antimicrobial Agents and ChemotherapyPeer-reviewed·Mar 15, 2022
- Repurposing azithromycin in combination with last-line fosfomycin, colistin and tigecycline against Multi-Drug Resistant Klebsiella pneumoniae
M. Gomara-Lomero, A. I. Lopez-Calleja, … S. Ramon-Garcia·bioRxiv·Jul 3, 2022
- Synergy pattern of short cationic antimicrobial peptides against multidrug-resistant Pseudomonas aeruginosa
S. Ruden, A. Rieder, … K. Hilpert·bioRxiv·May 17, 2019
- Assessing the efficacy of therapeutically promising combination of polymyxin B and triclosan against colistin resistant Klebsiella pneumoniae
Soumya Biswas, Pushney Mahapatra, … Mrutyunjay Suar·bioRxiv·Dec 17, 2024
- Effects of regulatory network organization and environment on PmrD connector activity and polymyxin resistance in Klebsiella pneumoniae and Escherichia coli
A. Chen, J. Zhu, M. Goulian·bioRxiv·May 5, 2020